NCT01713621View on ClinicalTrials.gov

OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Malaria
Interventions
DRUG

OZ439

OZ439 is a novel synthetic trioxolane antimalarial agent

Trial Locations (3)

10400

Faculty of Tropical Medicine,, Bangkok

63110

Shoklo Malaria Research Unit, Mae Sot

63140

Mae Ramat District hospital, Mae Ramat

All Listed Sponsors
lead

Medicines for Malaria Venture

OTHER

NCT01713621 - OZ439 PhIIa Study in Plasmodium Falciparum: Extended Observation | Biotech Hunter | Biotech Hunter